Del D Miller

Summary

Affiliation: University of Iowa
Country: USA

Publications

  1. ncbi request reprint Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis
    Del D Miller
    Department of Psychiatry, University of Iowa, Carver College of Medicine, Iowa City, IA 52242 1000, USA
    J Clin Psychiatry 68:1901-6. 2007
  2. pmc Extrapyramidal side-effects of antipsychotics in a randomised trial
    Del D Miller
    University of Iowa Carver College of Medicine, Iowa City, IA 52242 1000, USA
    Br J Psychiatry 193:279-88. 2008
  3. ncbi request reprint Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism
    Del D Miller
    Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, Iowa 52242 1000, USA
    Am J Med Genet B Neuropsychiatr Genet 133:97-100. 2005
  4. ncbi request reprint Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial
    Del D Miller
    University of Iowa Carver College of Medicine, Psychiatry Research, 2 105 MEB, 500 Newton Rd, Iowa City, IA 52242 1000, USA
    Schizophr Res 80:33-43. 2005
  5. ncbi request reprint The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update
    Troy A Moore
    Department of Psychiatry, The University of Texas Health Science Center at San Antonio, USA
    J Clin Psychiatry 68:1751-62. 2007
  6. pmc Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia
    Stanley N Caroff
    Department of Psychiatry, Veterans Affairs Medical Center and University of Pennsylvania School of Medicine, Philadelphia, USA
    J Clin Psychiatry 72:295-303. 2011
  7. pmc Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disorders
    Maithri Prabhakar
    Department of Psychiatry, Carver College of Medicine, College of Public Health, University of Iowa, Iowa City, USA
    Pharmacotherapy 31:806-12. 2011
  8. doi request reprint Substance use and schizophrenia: adverse correlates in the CATIE study sample
    Karin E Kerfoot
    Department of Psychiatry, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06510, USA
    Schizophr Res 132:177-82. 2011
  9. ncbi request reprint Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial
    Miranda H Chakos
    Department of Psychiatry, State University of New York Downstate Medical Center, Brooklyn, 11572, USA
    Psychiatr Serv 57:1094-101. 2006
  10. ncbi request reprint The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update
    Alexander L Miller
    Department of Psychiatry, The University of Texas Health Science Center at San Antonio, MC 7792, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
    J Clin Psychiatry 65:500-8. 2004

Research Grants

  1. ANTIPSYCHOTIC TREATMENT RESPONSE
    Del Miller; Fiscal Year: 2004
  2. Relapse Prevention: Long-Acting Atypical Antipsychotics
    Del Miller; Fiscal Year: 2007

Detail Information

Publications26

  1. ncbi request reprint Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis
    Del D Miller
    Department of Psychiatry, University of Iowa, Carver College of Medicine, Iowa City, IA 52242 1000, USA
    J Clin Psychiatry 68:1901-6. 2007
    ..To comparatively assess the incidence of tardive dyskinesia in patients with schizophrenia receiving either aripiprazole or haloperidol...
  2. pmc Extrapyramidal side-effects of antipsychotics in a randomised trial
    Del D Miller
    University of Iowa Carver College of Medicine, Iowa City, IA 52242 1000, USA
    Br J Psychiatry 193:279-88. 2008
    ..There are claims that second-generation antipsychotics produce fewer extrapyramidal side-effects (EPS) compared with first-generation drugs...
  3. ncbi request reprint Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism
    Del D Miller
    Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, Iowa 52242 1000, USA
    Am J Med Genet B Neuropsychiatr Genet 133:97-100. 2005
    ..Subjects without the -759T variant allele were at a greater risk for weight gain from clozapine over 6-months compared to those with the -759T allele...
  4. ncbi request reprint Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial
    Del D Miller
    University of Iowa Carver College of Medicine, Psychiatry Research, 2 105 MEB, 500 Newton Rd, Iowa City, IA 52242 1000, USA
    Schizophr Res 80:33-43. 2005
    ..To examine the clinical characteristics of individuals with schizophrenia that develop tardive dyskinesia (TD) associated with antipsychotic treatment...
  5. ncbi request reprint The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update
    Troy A Moore
    Department of Psychiatry, The University of Texas Health Science Center at San Antonio, USA
    J Clin Psychiatry 68:1751-62. 2007
    ....
  6. pmc Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia
    Stanley N Caroff
    Department of Psychiatry, Veterans Affairs Medical Center and University of Pennsylvania School of Medicine, Philadelphia, USA
    J Clin Psychiatry 72:295-303. 2011
    ..We compared the response to antipsychotic treatment between patients with and without tardive dyskinesia (TD) and examined the course of TD...
  7. pmc Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disorders
    Maithri Prabhakar
    Department of Psychiatry, Carver College of Medicine, College of Public Health, University of Iowa, Iowa City, USA
    Pharmacotherapy 31:806-12. 2011
    ..To identify the factors associated with newly prescribed, first-line, second-generation antipsychotics (SgAs) associated with weight gain-olanzapine, risperidone, and quetiapine...
  8. doi request reprint Substance use and schizophrenia: adverse correlates in the CATIE study sample
    Karin E Kerfoot
    Department of Psychiatry, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06510, USA
    Schizophr Res 132:177-82. 2011
    ....
  9. ncbi request reprint Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial
    Miranda H Chakos
    Department of Psychiatry, State University of New York Downstate Medical Center, Brooklyn, 11572, USA
    Psychiatr Serv 57:1094-101. 2006
    ..This study examined the prevalence and correlates of concomitant psychotropic medications and use of anticholinergic drugs to treat schizophrenia...
  10. ncbi request reprint The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update
    Alexander L Miller
    Department of Psychiatry, The University of Texas Health Science Center at San Antonio, MC 7792, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
    J Clin Psychiatry 65:500-8. 2004
    ..This article reports the recommendations developed in 2002 and 2003 by a group of experts, clinicians, and administrators...
  11. pmc Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents
    Chadi Albert Calarge
    Department of Psychiatry, The University of Iowa Carver College of Medicine, Iowa City, Iowa 52242, USA
    J Child Adolesc Psychopharmacol 21:163-9. 2011
    ..Little is known about risperidone metabolism in a clinical sample, where polypharmacy is common. Such knowledge is important since several of its side effects are dose dependent...
  12. pmc Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents
    Chadi A Calarge
    The University of Iowa Carver College of Medicine, Iowa, USA
    Pharmacogenet Genomics 19:373-82. 2009
    ..To investigate the association between hyperprolactinemia and variants of the dopamine D2 receptor (DRD2) gene in children and adolescents in long-term treatment with risperidone...
  13. pmc Evidence for accelerated vascular aging in bipolar disorder
    Simrit K Sodhi
    Department of Psychiatry, Roy J and Lucille A Carver College of Medicine, 200 Hawkins Drive, Iowa City, IA 52242 1057, United States
    J Psychosom Res 73:175-9. 2012
    ..We measured vascular stiffness in a cross-sectional sample of participants with bipolar disorder and compared results to published normative data to assess time-course and relationship to behavioral risk factors...
  14. pmc Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder
    Jess G Fiedorowicz
    Department of Psychiatry, Roy J and Lucille A Carver College of Medicine, The University of Iowa, Iowa City, Iowa, USA
    Ann Clin Psychiatry 20:131-7. 2008
    ..We hypothesized outpatients with bipolar disorder would exhibit excess cardiovascular risk factors, particularly among prevalent users of the second-generation antipsychotics associated with weight gain and valproic acid derivatives...
  15. ncbi request reprint The effects of neuroleptic medications on basal ganglia blood flow in schizophreniform disorders: a comparison between the neuroleptic-naïve and medicated states
    Patricia Westmoreland Corson
    Mental Health Clinical Research Center, Department of Psychiatry, The University of Iowa College of Medicine, Iowa City, Iowa 52242, USA
    Biol Psychiatry 52:855-62. 2002
    ..Subsequent exposure to neuroleptic medication appears to induce volumetric change. Possible reasons for this include differences in blood flow and metabolism between the neuroleptic-naïve and medicated states...
  16. ncbi request reprint Clozapine and tardive dyskinesia
    Del D Miller
    Am J Psychiatry 160:588. 2003
  17. ncbi request reprint Clinicians' recognition of the metabolic adverse effects of antipsychotic medications
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, 1515 Pope Avenue, Augusta, GA 30912 3800, USA
    Schizophr Res 79:281-8. 2005
    ..The extent of monitoring for metabolic adverse effects was low and inconsistent across measures and in frequency of evaluation. Ongoing efforts are needed to support and encourage change in clinician practice...
  18. ncbi request reprint Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study
    Marvin S Swartz
    Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC 27710, USA
    J Nerv Ment Dis 194:164-72. 2006
    ....
  19. pmc Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants
    Vicki L Ellingrod
    University of Michigan College of Pharmacy, Department of Clinical Sciences, School of Medicine, Ann Arbor 48109, USA
    Schizophr Res 98:47-54. 2008
    ....
  20. ncbi request reprint The relationship between P-glycoprotein (PGP) polymorphisms and response to olanzapine treatment in schizophrenia
    Ying Chi Lin
    Department of Clinical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, 48109, USA
    Ther Drug Monit 28:668-72. 2006
    ..The PGP C3435T genotype may help to determine positive symptom reduction from olanzapine clinically, but these findings should be replicated in a larger sample of subjects...
  21. ncbi request reprint Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia
    Vicki L Ellingrod
    Department of Psychiatry in the University of Michigan College of Pharmacy and College of Medicine, Ann Arbor, Michigan 48109, USA
    Psychopharmacol Bull 40:57-62. 2007
    ..The objective of the current investigation was to determine the relationship between polymorphisms of the leptin system (leptin gene and leptin receptor) and olanzapine-induced weight gain in persons with schizophrenia...
  22. doi request reprint Sex, race, and smoking impact olanzapine exposure
    Kristin L Bigos
    Department of Pharmaceutical Sciences, University of Pittsburgh, School of Pharmacy, 805 Salk Hall, 3501 Terrace St, Pittsburgh, PA 15261, USA
    J Clin Pharmacol 48:157-65. 2008
    ..0001). Differences in olanzapine exposure due to sex, race, and smoking may account for some of the variability in response to olanzapine...
  23. doi request reprint The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study
    Marvin S Swartz
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham NC 27710, United States
    Schizophr Res 100:39-52. 2008
    ..This double-blind study compared a second generation (atypical) antipsychotic drugs compared to a representative older agent for patients with schizophrenia who use or avoid illicit substances...
  24. ncbi request reprint Pharmacogenetics and schizophrenia
    Adriana Foster
    Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA 30912, USA
    Psychiatr Clin North Am 30:417-35. 2007
    ....
  25. ncbi request reprint Baseline neurocognitive deficits in the CATIE schizophrenia trial
    Richard S E Keefe
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
    Neuropsychopharmacology 31:2033-46. 2006
    ..Multiple analyses suggested that a broad cognitive deficit characterizes this sample. These deficits are modestly related to negative symptoms and essentially independent of positive symptom severity...
  26. ncbi request reprint Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE study
    Marvin S Swartz
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
    Psychiatr Serv 57:1110-6. 2006
    ..This study examined the relationship between substance use and psychosocial functioning in schizophrenia...

Research Grants4

  1. ANTIPSYCHOTIC TREATMENT RESPONSE
    Del Miller; Fiscal Year: 2004
    ..This award will also serve as a mechanism by which the candidate can establish professional collaborative relationships with his mentors and provide him with the background for ongoing research leading to an independent research career. ..
  2. Relapse Prevention: Long-Acting Atypical Antipsychotics
    Del Miller; Fiscal Year: 2007
    ..Even relatively modest delays in relapse and improvement of long term functioning potentially resulting from a long acting second-generation medication can translate into substantial public health benefits. ..